Contineum Therapeutics Inc (CTNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 0 | 50,000 | 0 |
| Gross Profit | N/A | 50,000 | N/A |
| Operating Expenses | 50,894 | 33,923 | 22,720 |
| Operating Income | -50,894 | 16,077 | -22,720 |
| Interest Expense | 0 | 208 | 388 |
| Other Income | 8,636 | 7,301 | -1,145 |
| Pre-tax Income | -42,258 | 23,170 | -24,253 |
| Income Tax | 0 | 450 | N/A |
| Net Income Continuous | -42,258 | 22,720 | -24,253 |
| Net Income | $-42,258 | $22,720 | $-24,253 |
| EPS Basic Total Ops | -2.18 | 1.36 | -10.81 |
| EPS Basic Continuous Ops | -2.18 | 9.84 | -10.81 |
| EPS Diluted Total Ops | -2.18 | 0.08 | -10.81 |
| EPS Diluted Continuous Ops | -2.18 | 6.69 | -10.81 |
| EPS Diluted Before Non-Recurring Items | -2.18 | N/A | N/A |
| EBITDA(a) | $-50,636 | $16,074 | $-22,237 |